Charles Homcy
2019
In 2019, Charles Homcy earned a total compensation of $6M as Chairman of Pharmaceuticals at BridgeBio Pharma.
Compensation breakdown
| Option Awards | $3,128,716 |
|---|---|
| Salary | $513,808 |
| Stock Awards | $2,111,579 |
| Other | $221,737 |
| Total | $5,975,842 |
Homcy received $3.1M in option awards, accounting for 52% of the total pay in 2019.
Homcy also received $513.8K in salary, $2.1M in stock awards and $221.7K in other compensation.
Rankings
In 2019, Charles Homcy's compensation ranked 1,722nd out of 13,971 executives tracked by ExecPay. In other words, Homcy earned more than 87.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,722 out of 13,971 | 88th |
Division Manufacturing | 615 out of 5,701 | 89th |
Major group Chemicals And Allied Products | 184 out of 2,200 | 92nd |
Industry group Drugs | 147 out of 1,886 | 92nd |
Industry Pharmaceutical Preparations | 109 out of 1,398 | 92nd |
Source: SEC filing on April 22, 2020.
Homcy's colleagues
We found two more compensation records of executives who worked with Charles Homcy at BridgeBio Pharma in 2019.